LGND · Ligand Pharmaceuticals Inc · Executive Compensation

$280.65 -3.82 (-1.34%) At close · Sep 14

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$5.67B

19.94M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd C. Davis	Chief Executive Officer	$724,500	—	$5,520,493	$4,441,120	$764,400	$21,582	$11,472,095
Tavo Espinoza	Chief Financial Officer	$522,825	—	$1,932,219	$1,554,411	$357,750	$14,943	$4,382,148
Andrew Reardon	Chief Legal Officer and Secretary	$476,675	—	$1,656,171	$1,332,345	$268,800	$13,291	$3,747,282

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Korenberg	Former President and Chief Operating Officer	$385,545	—	$6,716,643	$5,802,366	$142,789	$118,326	$13,165,669
Todd C. Davis	Chief Executive Officer	$695,834	—	$6,429,536	$5,142,650	$637,000	$9,960	$12,914,980
Tavo Espinoza	Chief Financial Officer	$469,550	—	$1,428,806	$1,142,820	$250,000	$7,380	$3,298,556
Andrew Reardon	Chief Legal Officer and Secretary	$451,950	—	$1,428,806	$1,142,820	$240,000	$7,380	$3,270,956

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd C. Davis	Chief Executive Officer	$650,007	—	$3,378,456	$1,788,095	$390,000	$9,960	$6,216,518
Matthew Korenberg	Former President and Chief Operating Officer	$549,912	—	$1,801,880	$953,640	$274,956	$6,900	$3,587,288
Tavo Espinoza	Chief Financial Officer	$433,005	—	$1,201,271	$635,773	$173,202	$7,380	$2,450,631
Andrew Reardon	Chief Legal Officer and Secretary	$434,262	—	$1,126,169	$596,045	$173,705	$6,900	$2,337,081

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	Former Chief Executive Officer	$675,264	—	$4,562,984	$5,178,758	—	$6,347,984	$16,764,990
Matthew Korenberg	Former President and Chief Operating Officer	$519,858	—	$2,691,809	$3,089,749	$234,229	$6,900	$6,542,545
Todd C. Davis	Chief Executive Officer	$49,243	—	$79,607	$5,001,298	—	$65,021	$5,195,169
Matthew Foehr	Former President and Chief Operating Officer	$451,057	—	$2,041,319	$1,400,037	—	$115,353	$4,007,766
Tavo Espinoza	Chief Financial Officer	$330,097	—	$1,385,048	$1,430,012	$119,715	$7,380	$3,272,252
Andrew Reardon	Chief Legal Officer and Secretary	$172,917	—	$1,023,470	$1,746,108	$62,250	$2,909	$3,007,654
Charles S. Berkman	Former Senior Vice President, General Counsel and Secretary	$396,920	—	$1,200,811	$823,556	—	$12,150	$2,433,437

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	Former Chief Executive Officer	$696,583	—	$6,016,298	$2,344,512	$522,438	$7,380	$9,587,211
Matthew Korenberg	President and Chief Operating Officer	$497,297	—	$4,890,114	$1,082,118	$248,649	$7,300	$6,725,479
Matthew Foehr	Former President and Chief Operating Officer	$518,933	—	$3,146,844	$1,226,357	$259,467	$130,603	$5,282,204
Charles S. Berkman	Former Senior Vice President, General Counsel and Secretary	$451,682	—	$1,665,811	$649,308	$203,257	$10,890	$2,980,948

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	Former Chief Executive Officer	$668,333	—	$2,277,460	$2,389,544	$501,250	$6,180	$5,842,767
Matthew Foehr	Former President and Chief Operating Officer	$503,750	—	$1,242,269	$1,303,366	$277,063	$158,001	$3,484,449
Matthew Korenberg	President and Chief Operating Officer	$482,833	—	$1,150,224	$1,206,821	$265,558	$5,700	$3,111,136
Charles S. Berkman	Former Senior Vice President, General Counsel and Secretary	$441,917	—	$644,168	$675,820	$176,767	$6,180	$1,944,852

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	Chief Executive Officer	$648,192	—	$2,933,389	$2,891,109	$291,686	$6,000	$6,770,376
Matthew Foehr	President and Chief Operating Officer	$487,500	—	$1,711,163	$1,686,480	$195,000	$164,766	$4,244,909
Matthew Korenberg	Executive Vice President, Finance and Chief Financial Officer	$466,667	—	$1,466,580	$1,445,555	$186,667	$5,734	$3,571,203
Charles S. Berkman	Senior Vice President and General Counsel	$427,620	—	$733,290	$722,777	$136,933	$6,547	$2,027,167

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	Chief Executive Officer	$627,413	—	$2,779,081	$2,376,729	$517,615	$5,965	$6,306,803
Matthew Foehr	President and Chief Operating Officer	$458,931	—	$1,361,147	$1,164,133	$252,412	$87,517	$3,324,140
Matthew Korenberg	Executive Vice President, Finance and Chief Financial Officer	$428,438	—	$1,077,560	$921,591	$235,641	$5,400	$2,668,630
Charles S. Berkman	Senior Vice President and General Counsel	$402,500	—	$623,961	$533,547	$177,100	$6,471	$1,743,579

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	Chief Executive Officer	$611,656	$30,000	$2,111,154	$2,202,412	$550,491	$7,494	$5,513,207
Matthew Foehr	President and Chief Operating Officer	$442,094	$30,000	$1,387,985	$1,280,493	$265,256	$52,675	$3,458,503
Matthew Korenberg	Executive Vice President, Finance and Chief Financial Officer	$403,438	$30,000	$736,550	$768,266	$242,063	$5,400	$2,185,717
Charles S. Berkman	Senior Vice President and General Counsel	$362,812	—	$466,461	$486,593	$174,150	$8,803	$1,498,819

Executive changes

Person	Role	Change	Effective	Filed
Martine Zimmermann, Pharm.D.	director of the Company	Appointed	2026-06-05	2026-06-09
John L. LaMattina, Ph.D.	director of the Company	Appointed	2026-06-05	2026-06-09
Stephen L. Sabba, M.D.	director of the Company	Appointed	2026-06-05	2026-06-09
John W. Kozarich, Ph.D.	director of the Company	Appointed	2026-06-05	2026-06-09
Jason Haas	director of the Company	Appointed	2026-06-05	2026-06-09
Nancy R. Gray, Ph.D.	director of the Company	Appointed	2026-06-05	2026-06-09
Todd C. Davis	director of the Company	Appointed	2026-06-05	2026-06-09
Jason M. Aryeh	director of the Company	Appointed	2026-06-05	2026-06-09
Martine Zimmermann	director	Appointed	—	2024-06-17
Stephen L. Sabba	director	Appointed	—	2024-06-17
Jason Haas	director	Appointed	—	2024-06-17
John L. LaMattina	director	Appointed	—	2024-06-17
John W. Kozarich	director	Appointed	—	2024-06-17
Nancy R. Gray	director	Appointed	—	2024-06-17
Todd C. Davis	director	Appointed	—	2024-06-17
Jason M. Aryeh	director	Appointed	—	2024-06-17

Key facts CIK 886163 CUSIP 53220K504 13F (30d) 16 filings 15 filers Visit website Investor relations